Left Ventricular Thrombus of Unknown Etiology in a Patient With COVID-19 Disease With No Significant Medical History

• Published in: Cardiovascular revascularization medicine Vol. 40; pp. 329 - 331
• Main Authors: Russell, Joseph, Wagoner, Michael, DuPont, James, Myers, Douglas, Muthu, Krishnakumar, Thotakura, Sudhir
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.2022
• Subjects: Arterial thromboembolism; Cardiovascular; Case Report; COVID-19; Left ventricular thrombosis; COVID-19; Left ventricular thrombosis; Arterial thromboembolism
• ISSN: 1553-8389; 1878-0938; 1878-0938
• DOI: 10.1016/j.carrev.2022.03.010

The incidence of left ventricular thrombus is relatively low. Ventricular thrombi typically manifest in patients with reduced ejection fraction and post myocardial infarction [1]. The impact of COVID-19's hypercoagulability state is presented here. A 44 year old male who contracted COVID-19, progressed to moderate disease requiring inpatient treatment with supplemental oxygen. During the course of the hospital stay, while receiving National Institutes of Health guideline directed thromboembolism prophylaxis for COVID-19 infected patients [2], the patient developed a left ventricular thrombus which consequently embolized and occluded the left anterior descending and left circumflex coronary arteries requiring rheolytic thrombectomy. •Seemingly healthymale adult contracts COVID-19 becomes hospitalized for respiratory failure due to moderate-severe COVID disease•While on guideline directed venous thromboembolism prophylaxis, patient develops left ventricular thrombus•Emboli from thrombous occlude left anterior descending coronary artery and near-occlude left circumflex coronary artery•Patient requires mechanical thrombectomy•Patient discharged with no known impact on cardiac function